N-Caffeoyldopamine (Compound 6i) is an amyloid-beta aggregation inhibitor. N-Caffeoyldopamine can inhibit Abeta aggregation to form nano-rod-like structures, thereby preventing beta-sheet formation. N-Caffeoyldopamine can be used for Alzheimers disease research[1].
Molecular Weight:
315.32
Purity:
90.00
Formula:
C17H17NO5
Target:
Amyloid-beta
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
